Cancer stem cell definitions and terminology: the devil is in the details (original) (raw)

• Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105–111 (2001).
  Article CAS PubMed Google Scholar
• Clarke, M. F. et al. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 66, 9339–9344 (2006).
  Article CAS PubMed Google Scholar
• Nguyen, L. V., Vanner, R., Dirks, P. & Eaves, C. J. Cancer stem cells: an evolving concept. Nature Rev. Cancer 12, 133–143 (2012).
  CAS PubMed Google Scholar
• Schulenburg, A. et al. Neoplastic stem cells: current concepts and clinical perspectives. Crit. Rev. Oncol. Hematol. 76, 2512–2520 (2010).
  Google Scholar
• Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23–81 (1976).
  CAS PubMed Google Scholar
• Baylin, S. B. & Jones, P. A. A decade of exploring the cancer epigenome - biological and translational implications. Nature Rev. Cancer 11, 726–734 (2011).
  CAS Google Scholar
• Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306–313 (2012).
  CAS PubMed PubMed Central Google Scholar
• Stratton, M. R. Exploring the genomes of cancer cells: progress and promise. Science 331, 1553–1558 (2011).
  CAS PubMed Google Scholar
• Magee, J. A., Piskounova, E. & Morrison, S. J. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21, 283–296 (2012).
  CAS PubMed PubMed Central Google Scholar
• Singh, A. & Settleman, J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29, 4741–4751 (2010).
  CAS PubMed PubMed Central Google Scholar
• Konopleva, M. Y. & Jordan, C. T. Leukemia stem cells and microenvironment: biology and therapeutic targeting. J. Clin. Oncol. 29, 591–599 (2011).
  PubMed PubMed Central Google Scholar
• Visvader, J. E. & Lindeman, G. J. Cancer stem cells: current status and evolving complexities. Cell Stem Cell 10, 717–728 (2012).
  CAS PubMed Google Scholar
• Gillies, R. J., Verduzco, D. & Gatenby, R. A. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nature Rev. Cancer 12, 487–493 (2012).
  CAS Google Scholar
• Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396–401 (2004).
  CAS PubMed Google Scholar
• Ponti, D. et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 65, 5506–5511 (2005).
  CAS PubMed Google Scholar
• Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111–115 (2007).
  CAS PubMed Google Scholar
• Eramo, A. et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 15, 504–514 (2008).
  CAS PubMed Google Scholar
• Han, M. E. et al. Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research. Cell. Mol. Life Sci. 68, 3589–3605 (2011).
  CAS PubMed Google Scholar
• Copley, M. R. Beer, P. A. & Eaves, C. J. Hematopoietic stem cell heterogeneity takes center stage. Cell Stem Cell 10, 690–697 (2012).
  CAS PubMed Google Scholar
• Bixby, S., Kruger, G. M., Mosher, J. T., Joseph, N. M. & Morrison, S. J. Cell-intrinsic differences between stem cells from different regions of the peripheral nervous system regulate the generation of neural diversity. Neuron 35, 643–656 (2002).
  CAS PubMed Google Scholar
• Van Keymeulen, A. & Blanpain, C. Tracing epithelial stem cells during development, homeostasis, and repair. J. Cell Biol. 197, 575–584 (2012).
  CAS PubMed PubMed Central Google Scholar
• Graf, T. & Enver, T. Forcing cells to change lineages. Nature 462, 587–594 (2009).
  CAS PubMed Google Scholar
• Doulatov, S., Notta, F., Laurenti, E. & Dick, J. E. Hematopoiesis: a human perspective. Cell Stem Cell 10, 120–136 (2012).
  CAS PubMed Google Scholar
• Smalley, M. J. et al. Isolation of mouse mammary epithelial subpopulations: a comparison of leading methods. J. Mammary Gland Biol. Neoplasia 17, 91–97 (2012).
  PubMed Google Scholar
• Wagers, A. J. & Conboy, I. M. Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 122, 659–667 (2005).
  CAS PubMed Google Scholar
• Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27–40 (2011).
  CAS PubMed PubMed Central Google Scholar
• Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012).
  CAS PubMed PubMed Central Google Scholar
• Sutherland, H. J., Lansdorp, P. M., Henkelman, D. H., Eaves, A. C. & Eaves, C. J. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc. Natl Acad. Sci. USA 87, 3584–3358 (1990).
  CAS PubMed PubMed Central Google Scholar
• Uchida, N. et al. Direct isolation of human central nervous system stem cells. Proc. Natl Acad. Sci. USA 97, 14270–14275 (2000).
  Google Scholar
• Dontu, G. et al. In vitro propagation and transcriptional profiling of human mammary/stem progenitor cells. Genes Dev. 17, 1253–1270 (2003).
  CAS PubMed PubMed Central Google Scholar
• Kamel-Reid, S. et al. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 246, 1597–1600 (1989).
  CAS PubMed Google Scholar
• Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645–648 (1994).
  CAS PubMed Google Scholar
• Sirard, C. et al. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87, 1539–1548 (1996).
  CAS PubMed Google Scholar
• Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983–3988 (2003).
  CAS PubMed PubMed Central Google Scholar
• O'Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106–110 (2007).
  CAS PubMed Google Scholar
• Stewart, J. M. et al. Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells. Proc. Natl Acad. Sci. USA 108, 6468–6473 (2011).
  CAS PubMed PubMed Central Google Scholar
• Prince, M. E. et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl Acad. Sci. USA 104, 973–978 (2007).
  CAS PubMed PubMed Central Google Scholar
• Taussig, D. C. et al. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 112, 568–575 (2008).
  CAS PubMed Google Scholar
• Taussig, D. C. et al. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34- fraction. Blood 115, 1976–1984 (2010).
  CAS PubMed PubMed Central Google Scholar
• Goardon, N. et al. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 19, 138–152 (2011).
  CAS PubMed Google Scholar
• Weinberg, O. K. & Arber, D. A. Mixed-phenotype acute leukemia: historical overview and a new definition. Leukemia 24, 1844–1851 (2010).
  CAS PubMed Google Scholar
• Kong, Y. et al. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia 22, 1207–1213 (2008).
  CAS PubMed Google Scholar
• Dirks, P. B. Brain tumor stem cells: the cancer stem cell hypothesis writ large. Mol. Oncol. 4, 420–430 (2010).
  PubMed PubMed Central Google Scholar
• Shmelkov, S. V. et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumours. J. Clin. Invest. 118, 2111–2120 (2008).
  CAS PubMed PubMed Central Google Scholar
• Quintana, E. et al. Phenotypic heterogeneity among tumourigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18, 510–523 (2010).
  CAS PubMed PubMed Central Google Scholar
• Quintana, E. et al. Efficient tumour formation by single human melanoma cells. Nature 456, 593–598 (2008).
  CAS PubMed PubMed Central Google Scholar
• Gupta, P. B., Chaffer, C. L. & Weinberg, R. A. Cancer stem cells: mirage or reality? Nature Med. 15, 1010–1012 (2009).
  CAS PubMed Google Scholar
• Gupta, P. B. et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146, 633–644 (2011).
  CAS PubMed Google Scholar
• Roesch, A. et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumour growth. Cell 141, 583–594 (2010).
  CAS PubMed PubMed Central Google Scholar
• Chaffer, C. L. et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc. Natl Acad. Sci. USA 108, 7950–7955 (2011).
  CAS PubMed PubMed Central Google Scholar
• Baylin, S. B. & Jones, P. A. A decade of exploring the cancer epigenome – biological and translational implications. Nature Rev. Cancer 11, 726–734 (2011).
  CAS Google Scholar
• Okita, K. & Yamanaka, S. Induced pluripotent stem cells: opportunities and challenges. Philosoph. Trans. R. Soc. B. Biol. Sci. 366, 2198–2207 (2011).
  CAS Google Scholar
• Akkina, R. et al. Humanized Rag1−/− γc−/− mice support multilineage hematopoiesis and are susceptible to HIV-1 infection via systemic and vaginal routes. PLoS ONE 6, e20169 (2011).
  CAS PubMed PubMed Central Google Scholar
• Strowig, T. et al. Transgenic expression of human signal regulatory protein α in Rag2−/−γc−/− mice improves engraftment of human hematopoietic cells in humanized mice. Proc. Natl Acad. Sci. USA 108, 13218–13223 (2011).
  CAS PubMed PubMed Central Google Scholar
• Wunderlich, M. et al. AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3. Leukemia 24, 1785–1788 (2010).
  CAS PubMed PubMed Central Google Scholar
• Takagi, S. et al. Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation. Blood 119, 2768–2777 (2012).
  CAS PubMed PubMed Central Google Scholar
• Lan, P., Tonomura, N., Shimizu, A., Wang, S. & Yang, Y. G. Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood 108, 487–492 (2006).
  CAS PubMed Google Scholar
• Petzer, A. L. et al. Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia. Blood 88, 2162–2171 (1996).
  CAS PubMed Google Scholar
• Blair, A., Hogge, D. E., Ailles, L. E., Lansdorp, P. M. & Sutherland, H. J. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 89, 3104–3112 (1997).
  CAS PubMed Google Scholar
• Garnett, M. J. et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483, 570–575 (2012).
  CAS PubMed PubMed Central Google Scholar
• Chen, J. et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488, 522–526 (2012).
  CAS PubMed PubMed Central Google Scholar
• Schepers, A. G. et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337, 730–735 (2012).
  CAS PubMed Google Scholar
• Driessens, G., Beck, B., Caauwe, A., Simons, B. D. & Blanpain, C. Defining the mode of tumour growth by clonal analysis. Nature 488, 527–530 (2012).
  CAS PubMed PubMed Central Google Scholar
• Domanska, U. M. et al. A review on CXCR4/CXCL12 axis in oncology: no place to hide. Eur. J. Cancer 8 Jun 2012 [epub ahead of print].
• Damon, L. E. & Damon, L. E. Mobilization of hematopoietic stem cells into the peripheral blood. Exp. Rev. Hematol. 2, 717–733 (2009).
  CAS Google Scholar
• Kessans, M. R., Gatesman, M. L. & Kockler, D. R. Plerixafor: a peripheral blood stem cell mobilizer. Pharmacotherapy 30, 485–492 (2010).
  CAS PubMed Google Scholar
• Burger, J. A. & Peled, A. CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia 23, 43–52 (2009).
  CAS PubMed Google Scholar
• Jin, L., Hope, K. J., Zhai, Q., Smadja-Joffe, F. & Dick, J. E. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nature Med. 12, 1167–1174 (2006).
  PubMed Google Scholar
• Florian, S. et al. Detection of molecular targets on the surface of CD34+/CD38- stem cells in various myeloid malignancies. Leuk. Lymphoma 47, 207–222 (2006).
  CAS PubMed Google Scholar
• Hosen, N. et al. CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia. Proc. Natl Acad. Sci. USA 104, 11008–11013 (2007).
  CAS PubMed PubMed Central Google Scholar
• Van Rhenen, A. et al. The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells. Blood 110, 2659–2666 (2007).
  CAS PubMed Google Scholar
• Jin, L. et al. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor α chain, eliminates human acute myeloid leukemic stem cells. Cell Stem Cell 5, 31–42 (2009).
  CAS PubMed Google Scholar
• Järås, M. et al. Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein. Proc. Natl Acad. Sci. USA 107, 16280–16285 (2010).
  PubMed PubMed Central Google Scholar
• Kemper, K., Grandela, C. & Medema, J. P. Molecular identification and targeting of colorectal cancer stem cells. Oncotarget 1, 387–395 (2010).
  PubMed PubMed Central Google Scholar
• Lorico, A. & Rappa, G. Phenotypic heterogeneity of breast cancer stem cells. J. Oncol. 2011, 135039 (2011).
  PubMed PubMed Central Google Scholar
• Korkaya, H. & Wicha, M. S. Selective targeting of cancer stem cells: a new concept in cancer therapeutics. BioDrugs 21, 299–310 (2007).
  CAS PubMed Google Scholar
• Valent, P. Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease. Br. J. Haematol. 142, 361–378 (2008).
  CAS PubMed Google Scholar
• Tu, L. C., Foltz, G., Lin, E., Hood, L. & Tian, Q. Targeting stem cells-clinical implications for cancer therapy. Curr. Stem Cell Res. Ther. 4, 147–153 (2009).
  CAS PubMed PubMed Central Google Scholar
• Gupta, P. B. et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138, 645–659 (2009).
  CAS PubMed PubMed Central Google Scholar
• Curtin, J. C. & Lorenzi, M. V. Drug discovery approaches to target Wnt signaling in cancer stem cells. Oncotarget 1, 563–577 (2010).
  PubMed PubMed Central Google Scholar
• Pannuti, A. et al. Targeting Notch to target cancer stem cells. Clin. Cancer Res. 16, 3141–3152 (2010).
  CAS PubMed PubMed Central Google Scholar
• Martelli, A. M. et al. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells. Curr. Med. Chem. 18, 2715–2726 (2011).
  CAS PubMed Google Scholar
• Allan, E. K., Holyoake, T. L., Craig, A. R. & Jørgensen, H. G. Omacetaxine may have a role in chronic myeloid leukaemia eradication through downregulation of Mcl-1 and induction of apoptosis in stem/progenitor cells. Leukemia 25, 985–994 (2011).
  CAS PubMed Google Scholar
• Takebe, N., Harris, P. J., Warren, R. Q. & Ivy, S. P. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nature Rev. Clin. Oncol. 8, 97–106 (2011).
  CAS Google Scholar
• de Sousa, E. M., Vermeulen, L., Richel, D. & Medema, J. P. Targeting Wnt signaling in colon cancer stem cells. Clin. Cancer Res. 17, 647–653 (2011).
  PubMed Google Scholar
• Wei, L. et al. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB. Breast Cancer Res. 13, R101 (2011).
  CAS Google Scholar
• Zuber, J. et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukemia. Nature 478, 524–528 (2011).
  CAS PubMed PubMed Central Google Scholar
• Dawson, M. A. et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia. Nature 478, 529–533 (2011).
  CAS PubMed PubMed Central Google Scholar
• Skrtic, M. et al. Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell 20, 674–688 (2011).
  CAS PubMed PubMed Central Google Scholar
• Sachlos, E. et al. Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. Cell 149, 1284–1297 (2012).
  CAS PubMed Google Scholar
• Valent, P. Targeting of leukemia-initiating cells to develop curative drug therapies: straightforward but nontrivial concept. Curr. Cancer Drug Targets 11, 56–71 (2011).
  CAS PubMed Google Scholar
• Barnes, D. J. & Melo, J. V. Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia. Cell Cycle 5, 2862–2866 (2006).
  CAS PubMed Google Scholar
• Irish, J. M., Kotecha, N. & Nolan, G. P. Mapping normal and cancer cell signalling networks: towards single-cell proteomics. Nature Rev. Cancer 6, 146–155 (2006).
  CAS Google Scholar
• Ho, M. M., Hogge, D. E. & Ling, V. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid Leukemia. Exp. Hematol. 36, 433–442 (2008).
  CAS PubMed Google Scholar
• Rosen, D. B. et al. Distinct patterns of DNA damage response and apoptosis correlate with Jak/Stat and PI3 kinase response profiles in human myelogenous Leukemia. PLoS ONE 5, e12405 (2010).
  PubMed PubMed Central Google Scholar
• de Jonge, H. J. et al. Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML. Leukemia 25, 1825–1833 (2011).
  CAS PubMed Google Scholar
• Eppert, K. et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nature Med. 17, 1086–1093 (2011).
  CAS PubMed Google Scholar
• Melo, J. V. & Ross, D. M. Minimal residual disease and discontinuation of therapy in chronic myeloid leukemia: can we aim at a cure? Hematol. Am. Soc. Hematol. Educ. Program 2011, 136–142 (2011).
  Google Scholar
• Liu, Y., Hernandez, A. M., Shibata, D. & Cortopassi, G. A. BCL2 translocation frequency rises with age in humans. Proc. Natl Acad. Sci. USA 91, 8910–8914 (1994).
  CAS PubMed PubMed Central Google Scholar
• Limpens, J. et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 85, 2528–2536 (1995).
  CAS PubMed Google Scholar
• Biernaux, C., Loos, M., Sels, A., Huez, G. & Stryckmans, P. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86, 3118–3122 (1995).
  CAS PubMed Google Scholar
• Cazzaniga, G. et al. Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia. Blood 118, 5559–5564 (2011).
  CAS PubMed PubMed Central Google Scholar
• Leary, R. J. et al. Development of personalized tumor biomarkers using massively parallel sequencing. Sci. Transl. Med. 2, 20ra14 (2010).
  PubMed PubMed Central Google Scholar